Bioceres Crop Solutions (NASDAQ:BIOX) Issues Earnings Results, Misses Expectations By $0.10 EPS

Bioceres Crop Solutions (NASDAQ:BIOX) posted its earnings results on Monday. The company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.10), MarketWatch Earnings reports. The company had revenue of $104.70 million during the quarter, compared to analyst estimates of $96.59 million. Bioceres Crop Solutions had a net margin of 3.56% and a return on equity of 5.37%. During the same quarter last year, the business posted ($0.12) EPS.

Bioceres Crop Solutions Stock Performance

BIOX opened at $11.00 on Wednesday. Bioceres Crop Solutions has a 1-year low of $9.76 and a 1-year high of $15.13. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.39 and a quick ratio of 0.89. The business has a 50 day moving average price of $12.14 and a two-hundred day moving average price of $11.82. The company has a market capitalization of $696.62 million, a price-to-earnings ratio of 55.00 and a beta of 0.42.

Analysts Set New Price Targets

Several analysts recently weighed in on BIOX shares. Roth Mkm reissued a “buy” rating and issued a $31.00 price objective on shares of Bioceres Crop Solutions in a report on Tuesday. Lake Street Capital dropped their target price on Bioceres Crop Solutions from $30.00 to $25.00 and set a “buy” rating on the stock in a research report on Tuesday. Four research analysts have rated the stock with a buy rating, According to MarketBeat.com, Bioceres Crop Solutions presently has an average rating of “Buy” and an average target price of $23.67.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Advisor Group Holdings Inc. raised its holdings in shares of Bioceres Crop Solutions by 66.9% in the 4th quarter. Advisor Group Holdings Inc. now owns 2,242 shares of the company’s stock worth $27,000 after purchasing an additional 899 shares in the last quarter. Lazard Asset Management LLC bought a new stake in shares of Bioceres Crop Solutions during the 4th quarter worth $49,000. Goldman Sachs Group Inc. acquired a new position in shares of Bioceres Crop Solutions in the 2nd quarter worth $176,000. Sei Investments Co. acquired a new position in shares of Bioceres Crop Solutions in the 2nd quarter worth $221,000. Finally, UBS Group AG purchased a new stake in shares of Bioceres Crop Solutions during the second quarter valued at $302,000. 13.35% of the stock is currently owned by institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates in three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops.